Creative Medical Technology Holdings, Inc. Weighted Average Limited Partnership Units Outstanding, Diluted
Creative Medical Technology Holdings, Inc. (CELZ) reported Weighted Average Limited Partnership Units Outstanding, Diluted of 2.45 million shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageLimitedPartnershipUnitsOutstandingDiluted · last filed 2021-11-15
- Creative Medical Technology Holdings, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2021-09-30 was 2.45M shares, a 10.04% decline year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2021-06-30 was 1.16B shares, a 585.75% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2021-03-31 was 1.24B shares, a 60.25% increase year-over-year.
- Creative Medical Technology Holdings, Inc. weighted average limited partnership units outstanding, diluted for the quarter ending 2020-09-30 was 2.73M shares.
| Period end | Weighted Average Limited Partnership Units Outstanding, Diluted 3 month | Weighted Average Limited Partnership Units Outstanding, Diluted 6 month | Weighted Average Limited Partnership Units Outstanding, Diluted 9 month |
|---|---|---|---|
| 2021-09-30 | 2.45M shares 10-Q · filed 2021-11-15 | 2.36M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 1.16B shares 10-Q · filed 2021-08-16 | 1.16B shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 1.24B shares 10-Q · filed 2021-05-17 | ||
| 2020-09-30 | 2.73M shares 10-Q · filed 2021-11-15 | 2.14M shares 10-Q · filed 2021-11-15 | |
| 2020-06-30 | 169.16M shares 10-Q · filed 2021-08-16 | 960.39M shares 10-Q · filed 2021-08-16 | |
| 2020-03-31 | 776.60M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |